🔗 Permalink

Inventor profile of:

Alan L. Epstein

City:

La Canada, California

Country:

United States

Published Applications:

Last publication date:

2020-03-12

Top Assignees for applications by Alan L. Epstein

The entities that hold a legal rights for patent applications filed by inventor Epstein Alan L.:

University of Southern California 9 Los Angeles, CA United States

Recent patent applications by Epstein Alan L.

Alan L. Epstein from La Canada, US has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2020-03-12

US20200079868A1

Chemistry; metallurgy

CD20 scFv-ELPs methods and therapeutics

#2 | 2015-08-06

US20150218280A1

Chemistry; metallurgy

CD20 scFv-ELPs METHODS AND THERAPEUTICS

#3 | 2014-08-05

US10779267

Compositions and methods for cancer immunotherapy

#4 | 2014-04-10

US20140099305A1

Human necessities

COMPOSITIONS AND METHODS FOR CANCER IMMUNOTHERAPY

#5 | 2012-03-29

US20120076804A1

Chemistry; metallurgy

Cancer targeted innate immunity

#6 | 2011-04-21

US20110091413A1

Chemistry; metallurgy

Methods of using interleukin-2 mutants with reduced toxicity

#7 | 2009-11-05

US20090274653A1

Chemistry; metallurgy

Therapeutic use of interleukin-2 mutants

#8 | 2008-05-13

US10218197

Interleukin-2 mutants with reduced toxicity

#9 | 2007-06-21

US20070141025A1

Human necessities

Compositions and methods for cancer immunotherapy

#10 | 2006-12-28

US20060292116A1

Chemistry; metallurgy

Therapeutic use of interleukin-2 mutants

#11 | 2006-06-22

US20060135459A1

Chemistry; metallurgy

Targeted innate immunity

#12 | 2005-09-29

US20050214286A1

Chemistry; metallurgy

Polymer-bound antibody cancer therapeutic agent

#13 | 2005-09-15

US20050201979A1

Chemistry; metallurgy

Interleukin-2 mutants with reduced toxicity

InventorID:

718860 ⎘